4.6 Review

Targeted lipidomics: Discovery of new fatty acyl amides

Journal

AAPS JOURNAL
Volume 8, Issue 3, Pages E461-E465

Publisher

AMER ASSOC PHARMACEUTICAL SCIENTISTS
DOI: 10.1208/aapsj080354

Keywords

lipidomics; cannabinoid; fatty acyl amide; information-dependent acquisition; HPLC-MS/MS; nano-HPLC

Funding

  1. NATIONAL INSTITUTE ON DRUG ABUSE [F32DA016825, R01DA020402, R01DA018224] Funding Source: NIH RePORTER
  2. NIDA NIH HHS [DA-020402, F32-DA-016825, DA-018224] Funding Source: Medline

Ask authors/readers for more resources

The discovery of endogenous fatty acyl amides such as N-arachidonoyl ethanolamide (anandamide), N-oleoyl ethanolamide (OEA), and N-arachidonoyl dopamine (NADA) as important signaling molecules in the central and peripheral nervous system has led us to pursue other unidentified signaling molecules. Until recently, technical challenges, particularly those associated with lipid purification and chemical analysis, have hindered the identification of low abundance signaling lipids. Improvements in chromatography and mass spectrometry (MS) such as miniaturization of high-performance liquid chromatography components, hybridization of multistage mass spectrometers and time-of-flight technology, the development of electrospray ionization (ESI) and of information-dependent acquisition, now permit rapid identification of novel, low abundance, signaling lipids.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available